Skip to main content
. 2022 Jul 19;12:12310. doi: 10.1038/s41598-022-16351-8

Table 1.

Baseline demographic, clinical and sampling characteristics.

NEC (n = 31) Controls (n = 31) p value
Center of birth (n [%]) 1.00
Centre No 1–2–3–4–5-6-7-8 8 [26]–6 [19]–1 [3]–3 [10]–2 [7]–4 [13]–1 [3]–6 [19] 8 [26]–6 [19]–1 [3]–2 [7]–2 [7]–3 [10]–2 [7]–7 [23]
Gestational age weeks (median [IQR]) 26+5 [25+2–27+6] 27 [26+1–27+6] 0.56
Birth weight grams (median [IQR]) 960 [755–1150] 988 [840–1150] 0.46
Gender female (n [%]) 11 [36] 14 [45] 0.44
Singleton (n [%]) 21 [68] 21 [68] 1.00
Mode of delivery vaginal (n [%]) 17 [55] 19 [61] 0.61
Apgar score 1 min (median [IQR]) 6 [5–8] 6 [3–7] 0.35
Apgar score 5 min (median [IQR]) 8 [6–9] 7 [6–8] 0.14
Average feeding practice from birth to t-1: 0.14
    Human milk > 75% per day (n [%]) 20 [65] 22 [71]
    Formula milk > 75% per day (n [%]) 4 [13] 1 [3]
    Combination of Human and Formula milk (n [%]) 5 [16] 3 [10]
Missing values (n [%]) 2 [6] 5 [16]
Primarily enterally fed at t-1Enteral feeding percentage > 75% of total volume (n [%]) 20 [65] 20 [65] 0.77
Missing values (n [%]) 5 [16] 4 [13]
Cumulative antibiotic administration by t-1 days (Median [IQR]) 6 [3–7] 4 [3–5] 0.17
Invasive ventilation at t-1 (n [%]) 8 [26] 4 [13] 0.22
NEC modified Bell’s stage NA NA
    IIIA (n [%]) 15 [48]
    IIIB (n [%]) 16 [52]
Age at diagnosis (t0) days (median [IQR]) 11 [8–14] NA NA
Laparotomy during NEC episode (n [%]) 19 [61] NA NA
Late-onset sepsis prior to sampling (n [%]) 12 [39] NA NA
Gram-negative LOS (n [%]) 2 [6]
Gram-positive LOS (n [%]) 9 [29]
Candida LOS (n [%]) 1 [3]
Sample availability (total count) 59 54
Time point t-1 (n [% of total samples]) 16 [27] 17 [31] 0.85
Time point t-2 (n [% of total samples]) 22 [37] 20 [37]
Time point t-3 (n [% of total samples]) 21 [35] 17 [31]
Sample age months (median [IQR]) 79 [65–92] 80 [70–99] 0.21

IQR interquartile range, n number of infants, LOS late-onset sepsis, NEC necrotizing enterocolitis, t0 day of diagnosis, t-1 1 day prior diagnosis, t-2 2 days prior diagnosis, t-3 3 days prior diagnosis.